NORTH AMERICAN BIOLOGICALS N&P/S 05/26/95

Company

Vaxart, Inc.

Filed

April 26, 1995

Period of Report

May 26, 1995

Accession Number

0000950144-95-001078

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →